BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

KRYS Stock News

Headlines matching Krystal Biotech or the KRYS ticker, most recent first.

  • Krystal Biotech(KRYS.US) 10% Shareholder Sells US$8.98 Million in Common StockMarket news · 5 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $441 PositiveMarket news · 24 Sep 2026 · Direct mention
  • BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $400 PositiveMarket news · 21 Sep 2026 · Direct mention
  • Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $386 PositiveMarket news · 4 Aug 2026 · Direct mention
  • BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Cuts Target Price to $392 NegativeMarket news · 4 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $361Market news · 4 Aug 2026 · Direct mention
  • TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $403Market news · 4 Aug 2026 · Direct mention
  • William Blair Maintains Krystal Biotech(KRYS.US) With Buy RatingMarket news · 4 Aug 2026 · Direct mention
  • RBC Capital Initiates Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $400Market news · 15 Aug 2026 · Direct mention
  • Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common StockMarket news · 15 Aug 2026 · Direct mention
  • Wolfe Research Maintains Krystal Biotech(KRYS.US) With Hold RatingMarket news · 12 Aug 2026 · Direct mention
  • BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $396 PositiveMarket news · 14 Jul 2026 · Direct mention
  • Jefferies Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $474 PositiveMarket news · 13 Jul 2026 · Direct mention
  • TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $403 PositiveMarket news · 18 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $361 PositiveMarket news · 16 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top